Cholestatic Liver Disease
Showing 1 - 25 of >10,000
Cholestatic Liver Disease Trial in Shanghai (Rich medium chain fatty acid milk powder group, Regular milk powder group)
Not yet recruiting
- Cholestatic Liver Disease
- Rich medium chain fatty acid milk powder group
- Regular milk powder group
-
Shanghai, Chinazhaoyang Gou
Jun 26, 2023
Osmotic Fragility in Red Blood Cells of Pediatric Cholestatic
Active, not recruiting
- Cholestasis
- Red Cell Membrane and Enzyme Abnormalities
- ektacytometry of red blood cells
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Oct 12, 2022
Hepatic Impairment, Cirrhosis, Cholestatic Liver Disease Trial in Indianapolis (Saroglitazar Magnesium 1 mg, Saroglitazar
Recruiting
- Hepatic Impairment
- +2 more
- Saroglitazar Magnesium 1 mg
- Saroglitazar Magnesium 2 mg
-
Indianapolis, IndianaIndiana University
Apr 23, 2022
Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, Cholangiocarcinoma Trial in Rochester
Recruiting
- Primary Sclerosing Cholangitis
- +3 more
-
Rochester, MinnesotaMayo Clinic
Feb 22, 2022
Cholestatic Liver Disease Trial in Worldwide (Maralixibat)
Active, not recruiting
- Cholestatic Liver Disease
-
Los Angeles, California
- +16 more
Jan 19, 2022
Alagille Syndrome Trial in Birmingham, Leeds, London (LUM001 (Maralixibat))
Completed
- Alagille Syndrome
- LUM001 (Maralixibat)
-
Birmingham, West Midlands, United Kingdom
- +2 more
Nov 17, 2021
Progressive Familial Intrahepatic Cholestasis, Alagille Syndrome, Cholestatic Liver Disease Trial in Worldwide (Maralixibat)
Recruiting
- Progressive Familial Intrahepatic Cholestasis
- +2 more
-
Los Angeles, California
- +13 more
Jul 18, 2022
Progressive Familial Intrahepatic Cholestasis (PFIC) Trial in Worldwide (LUM001 (Maralixibat))
Completed
- Progressive Familial Intrahepatic Cholestasis (PFIC)
- LUM001 (Maralixibat)
-
Los Angeles, California
- +9 more
Jun 16, 2021
Alagille Syndrome Trial in Canada, United States (LUM001 (Maralixibat))
Completed
- Alagille Syndrome
- LUM001 (Maralixibat)
-
Los Angeles, California
- +10 more
Jun 29, 2021
Cholestatic Liver Disease Trial in Jakarta Pusat (, probiotics)
Recruiting
- Cholestatic Liver Disease
- placebo
- probiotics
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo Hospital
Mar 5, 2021
Drug-Induced Liver Injury, Cholestatic Liver Injury, Mixed Liver Injury Trial in Shanghai (MT2004 Capsule, MT2004 Capsule
Recruiting
- Drug-Induced Liver Injury
- +2 more
- MT2004 Capsule
- MT2004 Capsule Placebo
-
Shanghai, Shanghai, ChinaShanghai Jiaotong University School of Medicine,Renji Hospital
Aug 25, 2023
Primary Biliary Cholangitis Trial in Birmingham (Home-based exercise program)
Terminated
- Primary Biliary Cholangitis
- Home-based exercise program
-
Birmingham, West Midlands, United KingdomLiver Unit, University Hospital Birminghmam
Jul 5, 2020
End Stage Liver DIsease Trial (sequential adolesent left lateral lobe liver transplantation (SALT))
Not yet recruiting
- End Stage Liver DIsease
- sequential adolesent left lateral lobe liver transplantation (SALT)
- (no location specified)
Oct 3, 2023
Liver Cirrhosis, Non-Alcoholic Fatty Liver Disease, Hepatocellular Carcinoma Trial in Roma (Handgrip strength test, total body
Recruiting
- Liver Cirrhosis
- +2 more
- Handgrip strength test
- +2 more
-
Roma, RM, ItalyCEMAD
Oct 20, 2023
Liver Fat Content and Bariatric Surgery
Recruiting
- Non-Alcoholic Fatty Liver Disease
- +2 more
- We do not have any intervention type
-
Qingdao, Shandong, ChinaQingdao University Affiliated Hospital
Sep 29, 2023
Non-Alcoholic Fatty Liver Disease Trial (Standard Soy Milk, 2% Fat Cow's Milk)
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Standard Soy Milk
- 2% Fat Cow's Milk
- (no location specified)
Nov 9, 2023
Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)
Not yet recruiting
- Fatty Liver, Nonalcoholic
- SGLT2 inhibitor
- (no location specified)
Oct 31, 2023
Type 2 Diabetes, Non Alcholic Fatty Liver Disease Trial (Bempedoic acid)
Not yet recruiting
- Type 2 Diabetes
- Non Alcholic Fatty Liver Disease
- Bempedoic acid
- (no location specified)
Sep 14, 2023
Patients With End Stage Liver Disease
Not yet recruiting
- Liver Cirrhosis
- +6 more
-
Palo Alto, CaliforniaStanford Hospital
Aug 23, 2023
Liver Cirrhosis Trial in New Delhi (EUS guided liver biopsy, Percutaneous Liver Biopsy)
Not yet recruiting
- Liver Cirrhosis
- EUS guided liver biopsy
- Percutaneous Liver Biopsy
-
New Delhi, IndiaInstitiute of liver and biliary sciences
Sep 20, 2023
Non-alcoholic Fatty Liver Disease in Low Birth Weight
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Low Birth Weight
- (no location specified)
Jun 6, 2023
Accurate Point of Care Liver Disease Diagnostics
Recruiting
- NAFLD
- Nonalcoholic Fatty Liver
- Liverscope® exam
- +5 more
-
La Jolla, CaliforniaUniversity of California San Diego
Aug 8, 2023
Non-Alcoholic Fatty Liver Disease Trial (Field-cycling imaging (FCI))
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Field-cycling imaging (FCI)
- (no location specified)
Apr 21, 2023
Transient Elastograghy to Detect Non Alcoholic Fatty Liver
Not yet recruiting
- Non-Alcoholic Fatty Liver Disease
- Renal Transplant Complication Pre-Existing Disease
- transient elastograghy
- (no location specified)
May 30, 2023